UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA

Clinical trials for UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New Three-Drug attack on tough sarcomas enters key test

Disease control Ongoing

This study is testing if a three-drug combination works better than a two-drug immunotherapy approach to control advanced soft tissue sarcoma. It will involve about 66 adults with specific types of sarcoma that have spread or cannot be surgically removed. The goal is to see if ad…

Matched conditions: UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA

Get alerted when new UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA trials appear

New Three-Drug attack on tough sarcomas enters key test